GlassScriptPhysician profile
Ashkan Ehdaie
NPI 1881846434
$56,010.76
in general payments reported to CMS, 2019-2025
17 companies · $37K in 2025
The $37K reported for 2025 was more than what 93% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,756 · 2020: $193 · 2021: $2,578 · 2022: $7,760 · 2023: $2,596 · 2024: $3,523 · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Consulting Fee: $14K · Food and Beverage: $6,755 · Travel and Lodging: $2,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,287.50 |
| Consulting Fee | $14,425.00 |
| Food and Beverage | $6,754.96 |
| Travel and Lodging | $2,255.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $21,476.85 | 2019-2025 | General - Ep, General - Brady, Farapulse |
| Abbott Laboratories | $15,662.99 | 2019-2025 | Ensite, Aveir, Tendril |
| Atricure, INC. | $9,529.31 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System |
| Biosense Webster, INC. | $4,893.59 | 2021-2024 | Carto 3, Na |
| Baylis Medical Company INC | $1,500.00 | 2021 | |
| Medtronic, INC. | $1,413.20 | 2022-2025 | Affera Mapping System, Selectsecure, Aurora Ev-Icd Mri Surescan |
| Siemens Medical Solutions USA, INC. | $900.00 | 2025 | |
| Amgen INC. | $162.16 | 2020-2024 | Repatha |
| Volta Medical INC | $130.31 | 2024 | Vx1 |
| Impulse Dynamics (USA) INC. | $94.37 | 2023-2024 | Optimizer, Optimizer |
| Janssen Pharmaceuticals, INC | $63.22 | 2022-2023 | Xarelto |
| Pfizer INC. | $55.86 | 2025 | |
| Bridgebio Pharma, INC. | $33.28 | 2025 | Attruby |
| Cordis US Corp. | $29.56 | 2024 | Mynx Venous Vcd |
| Edwards Lifesciences Corporation | $24.54 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $21.11 | 2025 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $20.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashkan Ehdaie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.